Oncology & Cancer

Researcher helps define subtypes of ovarian cancer

In a new paper published in the journal Clinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved the long-standing controversy over how to define molecular subtypes of high-grade serous ...

Oncology & Cancer

UVA developing 'two-headed arrow' to kill ovarian cancer

A University of Virginia School of Medicine researcher is developing a two-fisted, antibody-based approach to destroy deadly ovarian cancer—an approach he believes could also be modified to kill breast, prostate and other ...

Oncology & Cancer

Scientists detect new ovarian cancer target

Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium ...

Oncology & Cancer

Targeted 'click-to-release' chemotherapy gives good results in mice

Tagworks Pharmaceuticals, based at Radboud University Medical Center, has developed a new technique for the targeted delivery of chemotherapy for tumors in difficult cases. By way of controlled 'click-to-release' of the chemotherapy ...

Oncology & Cancer

Gene mapping lays groundwork for precision chemotherapy

Despite the great successes of targeted cancer drugs and the promise of novel immunotherapies, the vast majority of people diagnosed with cancer are still first treated with chemotherapy. Now a new study by UCSF researchers ...

page 9 from 25